Omicron BA.2 less severe than its original and Delta variants: Study

PTI, Oct 28, 2022, 11:56 AM IST

Representative Image (Source: ANI)

Washington: The Omicron BA.2 subvariant is less severe than the Delta variant and to an even greater extent than the original Omicron variant, according to a research team led by investigators at the US-based Massachusetts General Hospital.

Of 1,02,315 confirmed COVID-19 cases in the US from March 3, 2020 to June 20 this year, there were 20,770 labelled as Delta variants, 52,605 labelled as Omicron B.1.1.529 variants, the original Omicron variant, and 28,940 labelled as Omicron BA.2 subvariants, researchers found.

Mortality rates were 0.7 per cent for Delta, 0.4 per cent for the original Omicron variant and 0.3 per cent for Omicron BA.2.

The researchers said after adjustments, the odds of death were more than two times higher for the Delta and the original Omicron variant compared with Omicron BA.2.

Patients with Delta and original Omicron variants were also more likely to need hospitalisation, invasive ventilation and intensive care admissions, according to the study, which has been published in the Journal of the American Medical Association (JAMA) Network Open.

These findings suggest that the severity of SARS-Cov-2 may be diminishing, according to the study.

To provide an accurate assessment of the severity of SARS-Cov-2 variants above and beyond previous studies, the researchers used a method called entropy balancing to account for potential confounding factors such as prior infections, vaccinations, treatments and comorbidities.

The team applied this method to data leveraged from the Mass General Brigham’s electronic health record system that is linked to a COVID-19 vaccine registry, the researchers said.

“While the SARS-CoV-2 virus always has the potential to mutate to a more deadly form, when you look at the recent trajectory of Delta, Omicron BA.1, to Omicron BA.2, the virus seems to be getting intrinsically less severe. Hopefully this trend will continue,” the study’s lead author, Zachary Strasser, said.

“We can continue to use our analytics system and method to assess many other questions such as which vaccinations have the most impact on preventing long Covid, or whether certain treatments reduce the likelihood of long Covid,” Strasser said.

The Omicron variant of concern was the dominant one earlier in the year, circulating globally and accounting for nearly all sequences reported to GISAID, an initiative which promotes rapid sharing of data from all influenza viruses and the coronavirus causing COVID-19.

Omicron is made up of several sublineages, the most common ones reported at that time being BA.1, BA.1.1 and BA.2.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

How a century-old drug could revolutionise cobra bite treatment

Mumbai-based Instagram-influencer dies after falling into gorge while making video

Landslide disrupts traffic on Goa-Karnataka route; IMD issues ‘orange’ alert

BJP’s Suvendu Adhikari shares video of Palestinian flag being waved in Bengal, police say no info

BJP warns Cong to be prepared for people’s wrath for holding back job reservation bill in Karnataka

US cop who laughed after Indian student’s death fired

First Vice-Chancellor of MAHE, Professor Marthanda Varma Sankaran Valiathan no more

Related Articles More

How a century-old drug could revolutionise cobra bite treatment

Physical exercise triggers allergic reaction to certain foods

Want the health benefits of strength training but not keen on the gym? Try ‘exercise snacking’

Dengue cases in Karnataka cross 10,000 mark

An overview on sarcomas – A diverse group of rare cancer


Brahma Kumaris

Tapta Mudra Dharana

Banana Farming

Aghnashini River

Dr. Rajkumar

Latest Additions

Emergency period brought progress to Dakshina Kannada: Former Minister B. Ramanath Rai

Woman falls to death from Thane building during banter with colleague

Bring 100 MLAs, form govt: Akhilesh Yadav’s ‘monsoon offer’ amid BJP rift speculation

How a century-old drug could revolutionise cobra bite treatment

How a century-old drug could revolutionise cobra bite treatment

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.